Skip Navigation



JAC Advance Access published online on October 27, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh471
© 2004 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
54/6/1134    most recent
dkh471v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Thibault, F. M.
Right arrow Articles by Cavallo, J.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thibault, F. M.
Right arrow Articles by Cavallo, J.-D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received April 30, 2004
Revised September 9, 2004
Accepted September 20, 2004

Brief report

Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents

F. M. Thibault 1*, E. Hernandez 2, D. R. Vidal 1, M. Girardet 2, and J.-D. Cavallo 2

1 Centre de Recherches du Service de Santé des Armées Emile Pardé, Département de Biologie des Agents Transmissibles, 24 Avenue des Maquis du Grésivaudan, B.P. 87, F-38702 La Tronche, France
2 Service de Biologie Médicale, Hôpital d'Instruction des Armées Begin, 69 Avenue de Paris, F-94160 Saint-Mandé, France

* To whom correspondence should be addressed.
F. M. Thibault, E-mail: fthibault{at}crssa.net


  Abstract

Objectives: Fifty isolates of Burkholderia pseudomallei and 15 isolates of Burkholderia mallei were tested for their susceptibilities to 35 antimicrobial agents, including agents not previously tested against these bacteria.

Methods: MICs were determined by agar dilution in Mueller-Hinton medium.

Results: Among the antibiotics tested, lower MICs were obtained with imipenem, ceftazidime, piperacillin, piperacillin/tazobactam, doxycycline and minocycline. Fluoroquinolones and aminoglycosides had poor activities. A single clinical isolate of B. pseudomallei was resistant to ceftazidime, co-amoxiclav and doxycycline but remained susceptible to imipenem.

Conclusions: Although B. mallei MICs are often lower, the overall results underline the importance of resistance in both species. The susceptibilities measured are consistent with the current recommendations for the treatment of B. pseudomallei and B. mallei infections.

Keywords: melioidosis; glanders; MICs; resistance; biowarfare.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
V. Thamlikitkul and S. Trakulsomboon
In Vitro Activity of Doripenem against Burkholderia pseudomallei
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3115 - 3117.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Goodyear, L. Kellihan, H. Bielefeldt-Ohmann, R. Troyer, K. Propst, and S. Dow
Protection from Pneumonic Infection with Burkholderia Species by Inhalational Immunotherapy
Infect. Immun., April 1, 2009; 77(4): 1579 - 1588.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
V. Thamlikitkul and S. Trakulsomboon
In Vitro Activity of Tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis.
Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1555 - 1557.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Tomaso, H. C. Scholz, S. Al Dahouk, M. Eickhoff, T. M. Treu, R. Wernery, U. Wernery, and H. Neubauer
Development of a 5'-Nuclease Real-Time PCR Assay Targeting fliP for the Rapid Identification of Burkholderia mallei in Clinical Samples
Clin. Chem., February 1, 2006; 52(2): 307 - 310.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.